“…Coat proteins are also key antiviral therapeutic targets for many human viruses that infect humans, such as enterovirus A71, enterovirus D68, hepatitis B virus (HBV), and human immunodeficiency virus (HIV). Many compounds have been designed to target viral proteins: 3-(4-Pyridyl)-2-imidazolidinone derivatives (GPP3, EC 50 10 nM), licochalcone A (EC 50 9.30 μM), and aminothiazole derivatives (e.g., 12s , EC 50 0.27 μM) have been designed and synthesized using the enterovirus A71 CP as the target. − Pyrazolopyridine analogues (e.g., 7a , EC 50 16.7 μM) are antiviral compounds targeting the enterovirus D68 CP . Heteroaryldihydropyrimidines (e.g., GLS4, EC 50 0.012 mM) are antiviral drugs that target the HBV CP and induce aberrant self-assembly, and GS-6207 (EC 50 105 pM) is an HIV replication inhibitor that targets the HIV-1 CP …”